Frankfurt - Delayed Quote EUR
Ovid Therapeutics Inc. (1OT.F)
0.2260
+0.0300
+(15.31%)
As of 8:06:17 AM GMT+2. Market Open.
Environment, Social and Governance (ESG) Risk Ratings
Total ESG Risk Score
26.1
ESG Risk Score for Peers
| Name | Total ESG Risk score | E | S | G |
|---|---|---|---|---|
| BEAM.MX BEAM.MX,0P0001OPST,0 | 26 | -- | -- | -- |
| LP6.F Livzon Pharmaceutical Grp Inc.R | 26 | 4 | 14 | 8 |
| 1OT.F Ovid Therapeutics Inc. R | 26 | -- | -- | -- |
| JSS.DU Nxera Pharma Co. Ltd. R | 26 | -- | -- | -- |
| ZNTL Zentalis Pharmaceuticals, Inc. | 26 | -- | -- | -- |
Controversy Level Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are rated on a scale from one to five with five denoting the most serious controversies with the largest potential impact.
ESG data provided by Sustainalytics, Inc. Last Updated on 4/2025
1OT.F
Category Average
N/A None Controversy Level
None 4 Severe
-- 1OT.F
0.5 Category Average
Product Involvement Areas Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
Flags a company’s involvement in products, services and business activities commonly used for screening purposes.
| Products and Activities | Significant Involvement |
|---|---|
| Alcoholic Beverages | No |
| Adult Entertainment | No |
| Gambling | No |
| Tobacco Products | No |
| Animal Testing | Yes |
| Fur and Specialty Leather | No |
| Controversial Weapons | No |
| Small Arms | No |
| Catholic Values | No |
| GMO | No |
| Military Contracting | No |
| Pesticides | No |
| Thermal Coal | No |
| Palm Oil | No |
Related Tickers
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
1VT.MU Viking Therapeutics Inc
22.46
+0.42%
EXOZ eXoZymes, Inc.
13.53
+14.76%
AVBP ArriVent BioPharma, Inc.
21.08
+3.94%
RAPP Rapport Therapeutics, Inc.
11.38
-1.47%
GYRE Gyre Therapeutics, Inc.
9.19
+6.37%
BCAX Bicara Therapeutics Inc.
15.51
+12.23%
MBX MBX Biosciences, Inc.
8.99
+4.05%
SEPN Septerna, Inc.
6.14
+2.85%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%